VanEck Biotech ETF (SNSE:BBH)
Chile · Delayed Price · Currency is CLP · Price in USD 197.38
0.00 (0.00%)
At close: Apr 27, 2026
11.18% (1Y)
| Assets | n/a |
| Expense Ratio | n/a |
| PE Ratio | n/a |
| Dividend (ttm) | 856.35 |
| Dividend Yield | 0.48% |
| Ex-Dividend Date | Dec 22, 2025 |
| Payout Frequency | Annual |
| Payout Ratio | n/a |
| 1-Year Return | +11.78% |
| Volume | n/a |
| Open | n/a |
| Previous Close | 197.38 |
| Day's Range | n/a |
| 52-Week Low | 177.53 |
| 52-Week High | 198.74 |
| Beta | n/a |
| Holdings | n/a |
| Inception Date | Oct 24, 1999 |
About BBH
VanEck Biotech ETF is an exchange traded fund launched and managed by Van Eck Associates Corporation. The fund invests in public equity markets of the United States. It invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences, biotechnology sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the MVIS US Listed Biotech 25 Index, by using full replication technique. VanEck Biotech ETF was formed on October 24, 1999 and is domiciled in the United States.
Stock Exchange Santiago Stock Exchange
Ticker Symbol BBH
Performance
BBH had a total return of 11.78% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.78%.
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | 870.94108 CLP | Dec 26, 2025 |
| Dec 23, 2024 | 1,242.72531 CLP | Dec 24, 2024 |
| Dec 18, 2023 | 620.5764 CLP | Dec 22, 2023 |
| Dec 19, 2022 | 666.37958 CLP | Dec 23, 2022 |
| Dec 20, 2021 | 347.56986 CLP | Dec 27, 2021 |
| Dec 21, 2020 | 442.84299 CLP | Dec 28, 2020 |